{"AllianceGenome": "34400", "HGNC": "34400", "MIM": "611641", "_id": "641654", "_version": 1, "accession": {"genomic": ["AP003501.2", "CP068267.2", "NC_000011.10", "NC_060935.1", "NG_029603.1"], "protein": ["AAQ19120.1", "NP_001032647.2"], "rna": ["AY275431.1", "NM_001037558.4", "NR_170124.1"], "translation": [{"protein": "NP_001032647.2", "rna": "NM_001037558.4"}, {"protein": "AAQ19120.1", "rna": "AY275431.1"}]}, "ensembl": {"gene": "ENSG00000221932", "protein": "ENSP00000386143", "transcript": "ENST00000408930", "translation": [{"protein": "ENSP00000386143", "rna": "ENST00000408930"}], "type_of_gene": "protein_coding"}, "entrezgene": "641654", "exons": [{"cdsend": 124920017, "cdsstart": 124919750, "chr": "11", "position": [[124919249, 124920677]], "strand": 1, "transcript": "NM_001037558", "txend": 124920677, "txstart": 124919249}], "exons_hg19": [{"cdsend": 124789913, "cdsstart": 124789646, "chr": "11", "position": [[124789145, 124790573]], "strand": 1, "transcript": "NM_001037558", "txend": 124790573, "txstart": 124789145}], "generif": [{"pubmed": 25448679, "text": "ROS increase production of an alternately spliced form of X-box binding protein 1 (XBP1s) and XBP1s increases HEPN1 expression by binding to the HEPN1 promoter"}, {"pubmed": 25687183, "text": "the current study suggested an underlying mechanism that miR-21 directly target HEPN1 and inhibit its expression during the carcinogenesis of HCC. HEPN1 may thus be a candidate as a therapeutic target for patients with HCC."}], "genomic_pos": {"chr": "11", "end": 124920677, "ensemblgene": "ENSG00000221932", "start": 124919250, "strand": 1}, "genomic_pos_hg19": [{"chr": "11", "end": 124790573, "start": 124789146, "strand": 1}, {"chr": "11", "end": 124806308, "start": 124789089, "strand": -1}], "homologene": {"genes": [[9598, 101057279], [9606, 641654]], "id": 134601}, "ipi": "IPI00449996", "map_location": "11q24.2", "name": "hepatocellular carcinoma, down-regulated 1", "other_names": ["HEPACAM opposite strand 1", "cancer susceptibility gene HEPN1", "putative cancer susceptibility gene HEPN1 protein"], "pharmgkb": "PA162390850", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF271563", "relationship": "is"}, {"id": "GNF271565", "relationship": "is"}, {"id": "GNF271566", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_029603.1"], "protein": "NP_001032647.2", "rna": ["NM_001037558.4", "NR_170124.1"], "translation": {"protein": "NP_001032647.2", "rna": "NM_001037558.4"}}, "reporter": {"HG-U133_Plus_2": "238003_at", "HG-U95B": "59326_at", "HTA-2_0": ["TC11001149.hg.1", "TC11002415.hg.1"], "HuEx-1_0": ["3354380", "3396249"], "HuGene-1_1": ["7944911", "7952475"], "HuGene-2_1": ["16732956", "16745752"]}, "summary": "This gene is expressed predominantly in the liver. Transient transfection studies show the expression of this gene significantly inhibits cell growth, suggesting a role for this gene in apoptosis. Expression of this gene is down-regulated or lost in hepatocellular carcinomas (HCC), suggesting that loss of this gene is involved in carcinogenesis of hepatocytes (PMID:12971969). This gene maps to the 3'-noncoding region of the HEPACAM gene (GeneID:220296) on the antisense strand. [provided by RefSeq, Aug 2020].", "symbol": "HEPN1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1968842"}, "unigene": "Hs.159863", "uniprot": {"Swiss-Prot": "Q6WQI6"}}